Author Guidelines

Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at http://www.icmje.org/recommendations/). 

Via Medica strongly recommends journal editors to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct. For more information Authors, Readers and Editors may visit the COPE website: http://publicationethics.org/.

PREPARATION OF MANUSCRIPTS

The text of the manuscript should be written in „.doc” (MS Word). Is it advised to you the font size 12 and 1.5 space between the lines. The manuscript should contain: Title page, Abstract, Key words, Text, Acknowledgements), References, Charts and Figures. Abbreviations, if used, should be defined in brackets on their first appearance in the text. The abbreviations, that are not accepted by the international groups of experts, should be avoided.

Title page should carry the full title of the paper and a short title consisting of not more than 40 characters including spaces, the first name, middle initial, last name and the affiliations of each author should appear. The name, address and telephone/fax number of the author responsible for correspondence concerning the manuscript should appear on the title page.

Abstracts. An abstract of not more than 250 words should be provided on a separate page. Articles containing original data should include a structured abstract with the following four paragraphs, labeled: Background, Material and methods, Results, and Conclusions. The abstract should be followed by a list of 3–10 keywords or short phrases. When possible, the terms used should be from the Medical Subject Headings list of the Index Medicus.

References. References must be numbered consecutively as they are cited.

Journals. List consecutive reference number, list all authors when there are six or fewer; when there are seven or more, list the first three, then ‘et al.’, title, journal title (abreviated according to Index Medicus), year, volume (Arabic numerals), first and last page. Numbered references to personal communication, unpublished data, and manuscripts either ‘in preparation’ or ‘submitted for publication’ are unacceptable. If essential, such material may be incorporated in the appropriate place in the text.

Example. Eliasson M., Jansson J., Nilsson P., Asplund K. Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden. J. Hypertens. 1997; 15: 349–356.

Books. List consecutive reference number, last name and initial(s) of the author(s)/editor(s), title, the editor, place and year of publication. Reference to a specific chapter should include: last name and initials of its author(s), chapter title, last name and initials of the book author(s)/editor(s), title, the editor, place and year of publication and pages.

Example (book reference with different author and editor). Rosen M.R. Principles of cardiac electrophysiology. In: Kelley W.N. ed. Internal Medicine. J.B. Lippincott Company, Philadelphia 1992; 90–95.

Example (book reference with identical author and editor). Braunwald E. Heart Disease. W.B. Saunders Company, Philadelphia 1992; 393–418.

Tables should be numbered consecutively with the Arabic numerals. Each table should be titled and followed by appropriate clarifications. The position of tables should be indicated in the text. Figures and photographs should be numbered consecutively with the Arabic numerals and submitted in separate files. Each figure and each photograph should be titled and its position in the text should be indicated. Figures and photographs should be submitted as .tif, .jpg or .gif files with a resolution of at least 300 dpi.

SENDING THE MANUSCRIPT TO THE JOURNAL

The manuscripts are submitted electronically including tables, figures and photographs.

All manuscripts submitted should be accompanied by a covering letter including signed confirmation that:

— work has not been published or submitted elsewhere as defined earlier in this document;

— manuscript has been approved by all co-authors (if any), as well as by the responsible authorities at the institution where the work has been carried out;

— author(s) agree(s) to the automatic and free copyright transfer to the Publisher, if and when the work is accepted for publication;

— all sources of financial support have been fully disclosed;

— author(s) confirm(s) that (s)he is (they are) familiar with and will observe the Editorial Policy and Information for Authors included in "Palliative Medicine in Practice".

Conflict of interest. Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be communicated to the reader.

Because the essence of reviews and editorials is selection and interpretation of the literature, the Journal expects that authors of such articles will not have any financial interest in a company (or its competitor) that makes a product discussed in the article.

Journal policy requires that reviewers, associate editors, editors, and senior editors reveal in a letter to the Editor-in-Chief any relationships that they have that could be construed as causing a conflict of interest with regard to a manuscript under review. The letter should include a statement of any financial relationships with commercial companies involved with a product under study.

Legal relations between the Publisher and the author(s) are in accordance with Polish law and with international conventions binding on Poland. Any potential conflict of interest will be dealt with by the local court specific to the Publisher.

Disclosures of funding sources and conflicts of interest should be made in a separate section of the text and placed before the references.

Permissions. Materials previously published should be accompanied by written consent for reprinting both from the relevant. Publishers and the original authors. If it is possible to identify a patient from a case report, illustration or paper, etc. his/her written consent should be provided prior to publication.

Copyright transfer. In sending the manuscript the author(s) confirm(s) that (s)he has (they have) not previously submitted it to another journal (expect for abstracts of no more than 400 words) or published it elsewhere. The author(s) also agree(s), if and when the manuscript is accepted for publication, to automatic and free transfer of copyright to the Publisher allowing for the publication and distribution of the material submitted in all available forms and fields of exploitation. The author(s) accept(s) that the manuscript will not be published elsewhere in any language without the written consent of the copyright holder, i.e. the Publisher.

Disclaimer. Every effort is made by the Publisher and Editorial Board to see that no inaccurate or misleading data, opinion or statement appear in the "Palliative Medicine in Practice". However, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the responsibility of the respective contributor, sponsor or advertiser. Accordingly, the Publisher and the Editorial Board accept no liability whatsoever for the consequences of any such inaccurate of misleading data, opinion or statement. Every effort is made to ensure that drug doses and other quantities are presented accurately. Nevertheless, readers are advised that methods and techniques involving drug usage and other treatments described in the Journal, should only be followed in conjunction with the drug or treatment manufacturer’s own documentation as published in the country of the reader.

AUTHORSHIP

All collaborators who have made significant and substantial contributions to a study are considered coauthors. The nature and level of contribution of all authors of accepted manuscripts must be indicated, i.e. conception, design, execution and interpretation of the data being published, wrote the paper. An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Other contributions to the work, such as providing of reagents or analytic tools, should be listed in the Acknowledgements. Ghostwriting and guest-authorship are forbidden. In case of detecting ghost written manuscripts, actions will be taken involving both the submitting authors and the participants involved.

Author statement

Online Submissions

Already have a Username/Password for Palliative Medicine in Practice?

Go to Login

Need a Username/Password?

Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The manuscript has not been published previously and has not been submitted to the publisher of another journal (except for conference abstracts and proceedings).

  2. All co-authors identified as such (if applicable) are aware of and approve the content of the manuscript, and give consent for its publication.

  3. The author(s) declare(s) that the manuscript will not be published elsewhere and in any language without prior approval of the copyright holder.

  4. The author(s) declare(s) his/her/their knowledge of the manuscript submission rules of the "Palliative Medicine in Practice" journal and hereby oblige to conform to these rules.

  5. The author(s) authorize(s) the Editor to edit the submitted manuscript as necessary.

  6. The reported research has been performed in compliance with the Declaration of Helsinki and local regulations regarding animal research.

  7. All sources of funding have been identified in the manuscript.

  8. All conflicts of interest have been declared by the author(s).

  9. The author(s) declare(s) that the submitted manuscript is in accordance with the instructions for ensuring a blind review. i.e., no part of the manuscript text will allow the authors to be identified by the reviewers.

Copyright Notice

In sending the manuscript the author(s) confirm(s) that (s)he has (they have) not previously submitted it to another journal (expect for abstracts of no more than 400 words) or published it elsewhere. The author(s) also agree(s), if and when the manuscript is accepted for publication, to automatic and free transfer of copyright to the Publisher allowing for the publication and distribution of the material submitted in all available forms and fields of exploitation. The author(s) accept(s) that the manuscript will not be published elsewhere in any language without the written consent of the copyright holder, i.e. the Publisher.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Medycyna Paliatywna w Praktyce dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl